These funding is an agreement with the study have been carried out by Hajipour et al. that indicated the SLN-loaded Ellagic acid (EA) exhibited anticancer properties against the cancer cells by increasing Bax and decreasing BCL2 expression gene. This evidence concerns the gene BCL2 and cancer.